Login / Signup

BNT162b2 mRNA COVID-19 vaccine and booster in patients with autoimmune rheumatic diseases: a national cohort study.

Amir BieberIftach SagyLena NovackShay BrikmanRan AbuhasiraSnait AyalonIrina NovofastovskiMahmoud Abu-ShakraReuven Mader
Published in: Annals of the rheumatic diseases (2022)
Our results indicate that both the BNT162b2 mRNA COVID-19 vaccine and the booster are associated with better COVID-19 outcomes in patients with ARD.
Keyphrases
  • coronavirus disease
  • sars cov
  • respiratory syndrome coronavirus
  • binding protein
  • type diabetes
  • quality improvement
  • adipose tissue
  • insulin resistance